Skip to main content
HLB SCIENCE Inc. logo

HLB SCIENCE Inc. — Investor Relations & Filings

Ticker · 343090 ISIN · KR7343090007 KO Professional, scientific and technical activities
Open in API
Filings indexed 187 across all filing types
Latest filing 2026-01-08 Major Shareholding Noti…
Country KR South Korea
Listing KO 343090

About HLB SCIENCE Inc.

https://hlbscience.com/eng/index.php

HLB SCIENCE Inc. is a biopharmaceutical company specializing in the development of innovative drugs and diagnostics for infectious and immune-related diseases. The company's primary research focuses on creating therapeutics for sepsis, superbacteria infections, and Alzheimer's disease. Its key pipeline candidate for sepsis, DD-S052P, is a novel antibiotic designed to eliminate both bacteria and their associated endotoxins to mitigate cytokine storms. For Alzheimer's disease, HLB SCIENCE is advancing DD-A279, a treatment that modulates lipopolysaccharides (LPS) and gram-negative bacteria in the central nervous system. This therapeutic effort is complemented by the development of DD-A514, a diagnostic kit for the early detection of Alzheimer's.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically due to a merger) by major shareholders and their special related parties. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-01-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes therein. This falls under the category of 'Director's Dealing' (DIRS) as it details the share ownership and transaction history of a company executive (YOON JONG SUN).
2026-01-06 Korean
주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory notice regarding the suspension of stock trading for 'HLB Science' due to a merger with 'HLB'. It cites specific exchange regulations and provides a date for the suspension. Since it is a regulatory announcement regarding trading status and corporate action (merger-related suspension) rather than the merger agreement itself or a full report, it falls under the general regulatory filing category.
2025-12-23 Korean
전환청구권행사 (제4회차)
Regulatory Filings
2025-11-05 Korean
주주총회소집공고
Regulatory Filings
2025-10-29 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-10-27 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.